Johannes Schenkel

Prof. Dr. Johannes Schenkel

orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 1999 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
AMAna Martin-Villalba
Ana Martin-Villalba
IHIngrid Herr
Ingrid Herr
IJIrmela Jeremias
Irmela Jeremias
MHMichael Hahne
Michael Hahne
RBRoland Brandt
Roland Brandt
KDKlaus-Michael Debatin
Klaus-Michael Debatin
Programmed cell death plays an important role in the neuronal degeneration after cerebral ischemia, but the underlying mechanisms are not fully understood. Here we examined,in vivoandin vitro, whether ischemia-induced neuronal death involves death-inducing ligand/receptor systems such as CD95 and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). After reversible middle cerebral artery occlusion in adult rats, both CD95 ligand and TRAIL were expressed in the apoptotic areas of the postischemic brain. Further recombinant CD95 ligand and TRAIL proteins induced apoptosis in primary neurons and neuron-like cellsin vitro. The immunosuppressant FK506, which most effectively protects against ischemic neurodegeneration, prevented postischemic expression of these death-inducing ligands bothin vivoandin vitro. FK506 also abolished phosphorylation, but not expression, of the c-Jun transcription factor involved in the transcriptional control of CD95 ligand. Most importantly, inlprmice expressing dysfunctional CD95, reversible middle cerebral artery occlusion resulted in infarct volumes significantly smaller than those found in wild-type animals. These results suggest an involvement of CD95 ligand and TRAIL in the pathophysiology of postischemic neurodegeneration and offer alternative strategies for the treatment of cardiovascular brain disease.

4 February 1994 in Science
Verified
Journal Article
Closed access
PDF file
IFIris Ferber
Iris Ferber
GSGünter Schönrich
Günter Schönrich
JSJohannes Schenkel
Johannes Schenkel
AMAndrew L. Mellor
Andrew L. Mellor
GHGünter J. Hämmerling
Günter J. Hämmerling
BABernd Arnold
Bernd Arnold
Antigen-specific immunosuppression requires an understanding of the parameters that control peripheral T cell tolerance. A liver-specific inducible promoter was used to drive the expression of the major histocompatibility complex antigen K b in transgenic mice. Minute amounts of K b , expressed exclusively on hepatocytes, induced tolerance by partial down-regulation of the T cell receptor (TCR) on the self-reactive CD8 + cells. Contact of these tolerant T cells with high concentrations of K b after induction led to complete down-regulation of TCR. Thus, tolerant T cells are susceptible to further tolerogenic signals and reach different levels of tolerance depending on antigen dose.

1 May 1996 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MSMarina Schorpp
Marina Schorpp
Richard JägerRichard Jäger
Richard Jäger
KSKarl Schellander
Karl Schellander
JSJohannes Schenkel
Johannes Schenkel
EWErwin F. Wagner
Erwin F. Wagner
PAPeter Angel
Peter Angel

22 August 2000 in Circulation
Verified
Journal Article
Open access
PDF file
IJI. Jeremias
I. Jeremias
CKChristian Kupatt
Christian Kupatt
AMA. Martin-Villalba
A. Martin-Villalba
HHH. Habazettl
H. Habazettl
JSJohannes Schenkel
Johannes Schenkel
KDK. M. Debatin
K. M. Debatin
Background —The death of cardiac cells during ischemia and reperfusion is partially mediated by apoptosis, as seen, eg, in autopsy material of patients after acute myocardial infarction. Methods and Results —To study the role of CD95/Fas/Apo1 for induction of postischemic cell death, we used an ischemia/reperfusion model of isolated rat and mouse hearts in Langendorff perfusion. In this model, caspase-dependent apoptosis occurred during postischemic reperfusion. Moreover, soluble CD95 ligand/Fas ligand was released by the postischemic hearts early after the onset of reperfusion. In addition, this ligand was synthesized de novo under these circumstances. Similar findings were observed for other “death-inducing” ligands, such as tumor necrosis factor (TNF)-α and TNF-related apoptosis-inducing ligand. In primary adult rat myocyte culture, hypoxia and reoxygenation caused a marked increase in sensitivity to the apoptotic effects of CD95 ligand. Isolated hearts from mice lacking functional CD95 ( lpr ) display marked reduction in cell death after ischemia and reperfusion compared with wild-type controls. Conclusions —These data suggest that CD95/Apo1/Fas is directly involved in cell death after myocardial ischemia. The CD95 system might thus represent a novel target for therapeutic prevention of postischemic cell death in the heart.

1 July 2001 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PDF file
AMA Martin-Villalba
A Martin-Villalba
MHM Hahne
M Hahne
SKS Kleber
S Kleber
JVJ Vogel
J Vogel
WFW Falk
W Falk
PKP H Krammer
P H Krammer